Edition:
United Kingdom

People: Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

52.25USD
8:16pm BST
Change (% chg)

$1.30 (+2.55%)
Prev Close
$50.95
Open
$51.37
Day's High
$52.25
Day's Low
$50.96
Volume
33,073
Avg. Vol
201,879
52-wk High
$60.98
52-wk Low
$35.86

Janney, Daniel 

Mr. Daniel S. Janney is an independent Director of the Company . He is a Managing Director at Alta Partners, a life sciences venture capital firm, which he joined in 1996. Prior to joining Alta, from 1993 to 1996, he was a Vice President in Montgomery Securities' healthcare and biotechnology investment banking group, focusing on life sciences companies. Mr. Janney is a director of a number of companies including Allakos Inc., Evolve Biosystems, Inc., Prolacta Bioscience, Inc., Sutro Biopharma and Viveve Medical, Inc. He holds a Bachelor of Arts in History from Georgetown University and an M.B.A. from the Anderson School at the University of California, Los Angeles. We believe Mr. Janney's experience working with and serving on the boards of directors of life sciences companies and his experience working in the venture capital industry qualifies him to serve as a member of our Board.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 343,846
Long-Term Incentive Plans, USD --
All Other, USD 45,222
Fiscal Year Total, USD 389,068

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --